Pharmafile Logo
Pharmafocus logo
Advanced Search

Enbrel

Showing 13 posts of 28 posts found.

EMA inside

Sandoz announces biosimilar successes

December 8, 2015
Manufacturing and Production American Society of Hematology, Enbrel, Neulasta, Sandoz, ash, biosimilars, etanercept, pegfilgrastim

Novartis’ biosimilars division Sandoz has announced progress in its biosimilars programme, with its version of Amgen’s Neulasta proving as effective …

News
amgen_flag

Amgen agrees to $71m settlement over false advertising

August 19, 2015
Sales and Marketing Amgen, Aranesp, Enbrel

Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …

News

Pfizer, Novartis and Celgene among late-stage psoriasis trial advances

March 23, 2015
Sales and Marketing Celgene, Cosentyx, Enbrel, FDA, Novartis, Pfizer, otezla, psoriasis, tofacitinib

Pfizer bosses say they are confident of a positive FDA application for tofacitinib after announcing positive Phase III study results. …

News
Amgen HQ

Amgen to wield axe on 2,900 jobs

July 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …

News
Pfizer image

Profits drop for Pfizer

January 29, 2014
Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4

Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …

News
pfizer image

Mixed tale for Pfizer psoriasis drug

October 11, 2013
Sales and Marketing Enbrel, Pfizer, psoriasis, tofacitinib

Pfizer has seen its novel, oral Janus kinase (JAK) inhibitor tofacitinib turn in a mixed showing in late-stage trials in …

News
novartis image

Novartis compound beats Enbrel

July 9, 2013
Sales and Marketing Enbrel, Novartis, Pfizer, skin

One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …

News

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

News
Enbrel

Forecasting future launch success

September 8, 2011
Sales and Marketing Champix, Enbrel, forecast planning, forecasting

Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …

Feature
Merck & Co

Merck to develop biosimilar of Pfizer’s Enbrel

June 15, 2011
Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar

Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …

News
Blog footer

Digital Pharma: Pfizer, Enbrel and UK Google Adwords

October 22, 2010
Medical Communications ABPI Code of Practice, Digital Pharma blog, Enbrel, Google Adwards, PMCPA, Pfizer, pharma SEO

Pfizer is using Google Adwords in the UK to promote an online eCongress for healthcare professionals interested in its arthritis …

News

NICE re-thinks arthritis guidance

June 25, 2010
Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis

NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …

News

Patients on Enbrel work longer, says study

September 7, 2009
Research and Development, Sales and Marketing Enbrel, RA

 Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025